Navigation Links
Kenneth Buechler Elected Chairman of Sequenom Board of Directors

SAN DIEGO, March 17, 2015 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, today announced that its Board of Directors elected Kenneth Buechler, Ph.D. as Chairman of the Board, effective April 1, 2015.  Dr. Buechler succeeds Harry Hixson, Jr., Ph.D. who will retire from the position effective March 31, 2015, after 11 years of service.

"We are extremely appreciative of Dr. Hixson's commitment and service to the board of directors for the past 11 years," said Bill Welch, President and Chief Executive Officer of Sequenom. "His leadership and passion for innovation have played a significant role in Sequenom's success in the noninvasive prenatal testing market."

Incoming chairman, Dr. Buechler, has served on the board of directors since December 2009. Prior to joining Sequenom's board, he served as President and Chief Scientific Officer of Biosite Incorporated, which he co-founded. Prior to co-founding Biosite, Dr. Buechler was a senior research scientist for the diagnostics research and development group at Hybritech Incorporated. He also is a director of Quidel Corp., Sotera Wireless Inc., Edico Genome Inc., and Astute Medical Inc.

"I am honored to begin my new role and look forward to working closely with the board and Sequenom management team as the Company continues to expand its portfolio of tests to provide additional offerings to health care providers and their patients," said Dr. Buechler.

About Sequenom 

Sequenom, Inc. (NASDAQ: SQNM) is committed to enabling healthier lives through the development of innovative products and services.  The Company serves patients and physicians by providing early patient management information. 

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the development of innovative products and services, the anticipation of Dr. Buechler assuming the position of Chairman of the Board of Directors on April 1, 2015 and the continued expansion of its portfolio of tests to provide additional offerings to health care providers and their patients. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Risks are described more fully in the Company's filings with the Securities and Exchange Commission, including without limitation the Company's most recent Annual Report on Form 10-K and other documents subsequently filed with or furnished to the Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made. The Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

Logo -

SOURCE Sequenom, Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Healthcare Industry Leader Kenneth H. Paulus Joins Uroplastys Board of Directors
2. The Kenneth Rainin Foundation Continues its Commitment to Ending Inflammatory Bowel Disease, Awarding $1.5 Million in Research Grants
3. Luminex Technology Selected by Assurex Health
4. Varian Medical Systems Selected to Equip Two National Proton Therapy Centers in England
5. Advanced Cell Diagnostics RNAscope Technology Supports Biomarker-Selected Phase 2 Clinical Trial of Merrimack Pharmaceuticals MM-121
6. Microbial Robotics Selected to Present at CleanEquity Monaco 2015
7. Michael A. McManus, Jr., CEO of Misonix, Selected As A Top Micro-Cap CEO By ExecRank
8. goBalto Selected as a 2014 Red Herring Top 100 Global Company
9. Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit!
10. Eisais David Martin Elected as National Pharmaceutical Councils Chairman of the Board
11. ContraVir Pharmaceuticals Selected to Present at Cavendish Global Health Impact Forum
Post Your Comments:
(Date:1/8/2020)... ... 09, 2020 , ... R3 Stem Cell, the nation's leader ... The cryogenic freezer allows practices to have plenty of stem cell and exosome ... require cryogenic freezing. This may include a practice receiving the biologics with overnight ...
(Date:1/7/2020)... ... 07, 2020 , ... China’s NMPA (CFDA):, Latest Regulatory Updates ... EST, , China is the second-largest medical device and in ... 20 percent annual growth rate year after year. , Stay up to speed ...
(Date:1/3/2020)... , ... January 03, 2020 , ... Stay on top ... medical device and food industries. Access to all webinars is free, so be sure ... in your field. , Visit to see our upcoming webinars: , ...
Breaking Medicine Technology:
(Date:1/10/2020)... ... January 10, 2020 , ... Sigma Theta Tau International Honor Society of Nursing ... Awards. These awards are regarded as one of the most important and prestigious designations ... of the Year competition has recognized Sigma for the last 11 consecutive years. , ...
(Date:1/10/2020)... ... ... The value of healthy vision can’t be overstated, and the most potent ... doctor, Brent Bellotte MD., champions such proactive care, advising that annual examinations are pivotal ... that many take for granted until a problem occurs. Eye disease is very common ...
(Date:1/8/2020)... ... January 08, 2020 , ... ... life sciences teams, announced today that the company is rebranding as Red Nucleus ... learning and performance solutions for the life sciences industry. , The addition ...
(Date:1/8/2020)... (PRWEB) , ... January 08, 2020 , ... Quality ... of providing a holistic care approach and to maintain a comfortable and preferred lifestyle ... Kavall has a passion for holistic care and has been a leader in the ...
(Date:1/7/2020)... ... January 07, 2020 , ... Destressing the patient payment and billing ... AI automation are among the topics to be examined at the HFMA Western Symposium, ... Fricano, chief executive officer for Healthfuse, a leader in supporting hospitals to more effectively ...
Breaking Medicine News(10 mins):